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Hypoxanthine plus xanthine oxidase causes profound
natriuresis without affecting renal blood flow autoregulation
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dynamics and reabsorptive function and could mediate theHypoxanthine plus xanthine oxidase causes profound natriure-
functional tubular consequences of ischemia/reperfusion.sis without affecting renal blood flow autoregulation.
Background. Enhanced superoxide (O•2 ) production by
xanthine oxidase in ischemia/reperfusion has been implicated
in structural damage. The reperfusion phase is accompanied
Reactive oxygen species (ROS), and superoxide (O•2 )by decreased tubular sodium reabsorption, which has been
in particular, have been recognized as important media-partly attributed to enhanced action of O•2 . In the present
study we assessed whether intrarenal increases of O•2 accom- tors of acute and chronic [1, 2] disease states. In particu-
plished by concomitant intrarenal hypoxanthine and intrave- lar, enhanced O•2 production by xanthine oxidase innous xanthine oxidase (HX/XO) infusion would decrease or ischemia/reperfusion has been implicated in structuralincrease sodium excretion, and whether HX/XO infusion could
damage [2]. Postoperative renal failure is an independentbe responsible for the diminished efficacy of renal blood flow
(RBF) autoregulation in ischemia/reperfusion. correlate of mortality after aortic aneurysm repair [3].
Methods. In the first group of Sprague-Dawley rats, renal The reperfusion phase is accompanied by decreased tu-
sodium handling was measured before and during O•2 infusion. bular sodium reabsorption, which has been partly attrib-
In the second group, renal hemodynamics and RBF autoregula-
uted to enhanced action of O•2 . Patients who fail totion were assessed.
regain adequate renal function after renal transplanta-Results. Intrarenal O•2 infusion dramatically increased urine
flow from 14.5  2.0 L/min to 46.3  4.4 L/min, urinary tion also show persistent impairment of sodium reab-
excretion of sodium (UNaV) from 1.7  0.4 mol/min to 8.6  sorption [4]. Studies on this issue have been performed
0.9 mol/min, and fractional excretion of sodium FENa from in isolated organs [5, 6] or in models of ischemia/reperfu-1.2  0.4% to 7.6  1.2%. Urinary excretion of thiobarbituric
sion [7–9]. The complexity of the ischemia/reperfusionacid reactive substances (TBARS), a measure of lipid peroxida-
model does not allow dissection of the actions of super-tion, increased during HX/XO infusion. These changes were
completely reversible. Glomerular filtration rate (GFR) de- oxide, and addressing this issue in the in vitro perfused
creased from 1.12  0.08 during baseline to 0.79  0.06 during kidney is hampered by the ischemic condition of this
HX/XO (P 0.05) and tended to increase toward baseline during
preparation and the already extremely high sodium ex-recovery (0.84  0.06 mL/min/g kidney weight). HX/XO did
cretion. The actions of hypoxanthine/xanthine oxidase–not significantly affect mean arterial pressure (MAP). HX/XO
decreased RBF in the second group from 8.4  0.6 mL/min/g generated O•2 on renal sodium handling have not yet
kidney weight to 7.4  0.5 mL/min/g kidney weight (P  0.05) been investigated in vivo.
and renal vascular resistance (RVR) slightly increased from Conflicting effects of O•2 on renal sodium handling13.8  0.9 units under baseline conditions to 15.1  1.1 units
have been reported. In experimental hypertension, theduring HX/XO infusion (P  0.05). HX/XO did not signifi-
actions of O•2 have been assessed using compounds thatcantly affect RBF autoregulation. Proteinuria and glucosuria
were absent and light microscopy revealed no renal morpho- increase prevailing O•2 by inhibiting O•2 breakdown [10],
logic changes. or by decreasing available O•2 by mimicking superoxideConclusion. Intrarenal O•2 infusion (1) dramatically in- dismutase (SOD) [11]. These reports indicate that O•2creased sodium and volume excretion and (2) did not affect
leads to renal vasoconstriction [10, 11] and decreasesautoregulation of RBF. Thus, superoxide can markedly affect
glomerulotubular balance by diverging actions on renal hemo- sodium excretion [10, 12]. Proposed sources of superox-
ide in chronic hypertension include nicotinamide ade-
nine dinucleotide phosphate (NADPH) oxidase [13, 14]Key words: hypoxanthine, reactive oxygen species, ischemia/reperfu-
sion. and uncoupling of nitric oxide synthases (NOSs) [15].
In such situations most of the ROS production will beReceived for publication October 3, 2002
intracellular. However, ischemia/reperfusion results in aand in revised form January 2, 2003
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sion. In this period, there is also a rapid increase in proached by a flank incision, freed from surrounding
tissue, and placed into a plastic holder; the left uretersuperoxide production in the kidney, the main source of
which is the reaction of xanthine with xanthine oxidase was cannulated with PE-10 tubing. A 1RB ultrasonic
flow probe was placed around the left renal artery and(XO). This reaction may well take place in the extracellu-
lar compartment, considering the delivery of oxygen in connected to a transit time blood flow meter (model
T206; Transonics, Ithaca, NY, USA). A sling was placedthe reperfusion phase. In this situation, decreasing ROS,
by mimicking SOD or by thiol-containing agents, de- around the aorta between the renal arteries to enable
reduction of the left renal perfusion pressure (RPP).creases sodium excretion [16, 17]. These compartmental
differences in O•2 generation may well underlie the obvi- All animals received an intravenous infusion of a 150
mmol/L NaCl solution containing 6% bovine serum albu-ous contrast between the enhanced sodium reabsorption
in hypertension and the reduced sodium reabsorption in min (BSA) (Sigma Chemical Co., St. Louis, MO, USA)
at a rate of 10 L/min/100 g body weight. Followingischemia/reperfusion.
In the present study, we addressed the question whether surgery, the infusion was switched to a 150 mmol/L NaCl
solution with 1% BSA at the same infusion rate. Thisincreases of O•2 accomplished by the enzymatic reaction
of hypoxanthine (HX) with XO (HX/XO), which is the infusion was maintained throughout the experiment. The
solutions also contained 15% polyfructosan (Inutest;proposed pathway of O•2 formation in reperfusion in-
jury, would increase sodium excretion. The results were Fresenius Pharma, Linz, Austria) for measurement of
renal clearance. Experimental compounds were added tostriking. HX/XO infusion resulted in a very pronounced
increase in fractional sodium excretion. Autoregulation this standard solution. A 60-minute equilibration period
was observed before the start of the measurements. Atof renal blood flow (RBF) is impaired in ischemia/reper-
fusion [18], and superoxide may well modulate the auto- the end of each experiment, the kidneys were removed,
blotted dry, weighed, formaldehyde-fixed, and stainedregulatory process. We therefore also assessed whether
the same HX/XO infusion that caused the natriuresis by periodic-acid Schiff (PAS) for light microscopy.
could be responsible for the diminished efficacy of RBF
Autoregulation assessmentautoregulation.
RBF autoregulation was assessed as described pre-
viously [19]. Briefly, a baseline measurement of RBF and
METHODS
MAP was obtained. Then, RPP was reduced in random
Animals order to 60, 70, 80, 90, 100, 110, 120, and, if applicable,
to 130 and 140 mm Hg by adjusting the sling around theMale Sprague-Dawley rats (200 to 250 g) (Harlan-
Olac, Blackthorn, Bicester, Oxon, UK) received normal aorta. Following each reduction in RPP, the RBF was
recorded for at least 20 to 30 seconds. Following eachrat chow (Hope Farms, Woerden, The Netherlands) (so-
dium content, 100 mmol/kg) and had free access to tap measurement at reduced RPP, the sling was released
and RPP and RBF were allowed to return to baselinewater. Sentinel animals were monitored regularly for
infection by nematodes and pathogenic bacteria, as well values. After adding the HX/XO infusion and in the
recovery period, we waited at least 30 minutes beforeas antibodies for a large number of rodent viral patho-
gens, and were consistently negative throughout the course recording another curve.
of the experiments. The Utrecht University Board for
ProtocolsStudies in Experimental Animals approved the studies.
In the first set of experiments, renal hemodynamic and
Surgical procedure and infusions excretory responses (GFR, MAP, urine flow, urinary excre-
tion of sodium, protein and glucose excretion, and urineOn the day of the experiment, the animals were anes-
thetized with inactin (110 mg/kg body weight intraperito- osmolality) were measured prior to and during intrarenal
infusion of XO (0.05 U/mL, 10L/min) and concomitantneally) and placed on Servo-controlled surgical table that
maintained rectal temperature at 37C. After intubation intravenous HX (10 mmol/L, 30 L/min; N  8) for 40
minutes after equilibration of 1 hour. In a small pilotof the trachea, a catheter was placed into the left jugular
vein (PE-50) (polyethylene) for infusion of solutions and study (N  3), we evaluated the effects of HX alone,
and observed no major effects on GFR, RBF, or sodiuma second catheter (PE-10) was introduced for bolus injec-
tions. Via the carotid artery, a tapered PE-10 catheter excretion. In order to assess the intrarenal increase in
oxidative stress achieved by the HX/XO infusion, wewas placed into the left renal artery for the intrarenal
infusion of the solutions. The left femoral artery was measured the urinary excretion of thiobarbituric acid
reactive substances (TBARS) during the same periods.cannulated (PE-50) to measure mean arterial pressure
(MAP) and to collect blood samples. A flared PE-50 The HX/XO infusion was discontinued and recovery ob-
served for 40 minutes after washout of 1 hour. Becausecatheter was placed in the bladder for collection of the
urine from the right kidney. The left kidney was ap- renal excretory function cannot be adequately assessed
Racasan et al: Superoxide causes profound natriuresis228
in combination with measurement of RBF autoregula-
tion, we assessed renal hemodynamic responses (MAP,
RBF, and RBF autoregulation) prior to and during
HX/XO infusion (N 8) in a second set of experiments.
Renal hemodynamics were assessed prior to, during
HX/XO infusion, and following cessation of the HX/XO
infusion.
Analyses
Hematocrit was measured with a Hawksley microhem-
atocrit centrifuge. Inulin was photometrically deter-
Fig. 1. Glomerular filtration rate (mL/min/g kidney weight) (A ), frac-mined with indolacetic acid after hydrolyzation to fruc-
tional sodium excretion (%) (B ), and urinary excretion of thiobarbiturictose [20]. Sodium and potassium concentrations were acid reactive substances (nmol/min) (C ) prior to baseline, during hypo-
measured with an IL 543 flame photometer (Instrumen- xanthine/xanthine oxidase (HX/XO) infusion, and during recovery.
*P  0.05 vs. baseline.tation Laboratory, Lexington, MA, USA). Coomassie
blue was used to determine urine protein concentration.
Osmolality was measured by freezing point depression
on an Advanced 3 MO Micro-osmometer (Advanced
RESULTSInstruments, Newton Highlands, MA, USA) [21]. Glu-
In vitro O•2 production by HX/XOcose was measured enzymatically (Trinder; Sigma Chem-
ical Co.). TBARS, a quantitative indicator of lipid perox- To ensure the efficacy of the HX/XO infusion to gener-
idation, were measured in equal aliquots of urine or ate O•2 , O•2 production was assessed using LEC. HX/XO
malondialdehyde standards mixed with thiobarbituric (10 mmol/L/300 U/mL) resulted in a LEC signal of 39
acid 1% (pH 1.5), and boiled for 30 minutes. After cool- 10 counts/mL/sec (N  5), indicating O•2 generation.
ing down at room temperature, the absorbance was mea-
sured at 540 nm using a microplate reader [22]. The HX/XO infusion results in profound natriuresis
measurement of O•2 in the solutions used for infusion In the first set of experiments, the responses of GFR
was done by lucigenin-enhanced chemiluminescence and renal hemodynamic and excretory parameters to
(LEC) using a LUMAT LB 9507 (Berthold; Wildbad, HX/XO in the presence and absence of L-NNA were
Germany) luminometer. investigated and served to investigate whether the effects
of HX/XO infusion were reversible. HX/XO infusionCalculations and statistics
decreased RBF to 80% and decreased GFR to 70% of
GFR, filtration fraction, urinary sodium and potassium baseline. Urine flow dramatically increased from 14.5 
excretion, and fractional excretions were calculated us- 2.0L/min to 46.3 4.4 L/min. Similarly, sodium excre-
ing standard formulas. The RBF autoregulation curve
tion and fractional sodium excretion increased (Fig. 1).
was generated by extrapolating the values of RBF at
Potassium excretion did not change significantly, and
different levels of RPP by linear regression to exact val-
urine osmolality decreased (Table 1). Following cessa-ues of 60, 70, 80, 90, 100, 120, and if possible to 130, 140
tion of HX/XO infusion, RBF and GFR tended to returnand 150 mm Hg. Renal vascular resistance (RVR) was
to baseline levels, however, this was incomplete. Urinecalculated as RPP divided by RBF. The lower limit of
flow and sodium excretion decreased to values not sig-autoregulation and the degree of compensation were
nificantly different from baseline after cessation of HX/XOcalculated as outlined previously [19]. The degree of
infusion. HX/XO infusion increased urinary excretioncompensation is a measure of autoregulatory efficiency.
of TBARS, a measure of lipid peroxidation, which wasWhen there is no change in RBF upon a decrease in
completely normalized in the recovery period (Fig. 1).RPP, the value is 100%. When the change in RBF equals
Protein and glucose excretions were not affected by thethe change expected if the vascular bed would not auto-
HX/XO infusion (data not shown). Light microscopyregulate, the value is zero. Values are expressed as
revealed no tubular or glomerular damage.mean SEM. Data are compared with two-way analysis
of variance (ANOVA) and two-way ANOVA for re-
RBF autoregulation is not affected by HX/XO infusionpeated measurements. If a variance ratio reached statisti-
Figure 2 shows the autoregulation curves obtained incal significance (P  0.05), the Student-Newman-Keuls
the second set of experiments. Infusion of HX/XO didtest was performed as post-hoc test. In cases when data
not result in a significant change in autoregulation, aswere not normally distributed, a two-way repeated mea-
sured ANOVA on ranks was employed. can be observed from the RBF/RPP relationships. The
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Table 1. Systemic and renal clearance data of rats subjected to the hypoxanthine/xanthine oxidase infusion (HX/XO)
Baseline HX/XO Recovery
MAP mm Hg 1192 1203 1232
Ht % 451 471 461
RBF mL/min/g kidney weight 9.10.9 7.31.0a 8.21.0a
RVR units 12.71.2 16.52.2 15.32.2
GFR mL/min/g kidney weight 1.120.08 0.790.06a 0.840.06a
Filtration fraction % 265 255 223
Urine flow lL/min 14.52.0 46.34.4a 23.133.3
UNaV lmol/min 1.70.4 8.60.9a 2.60.3
FENa % 1.20.4 7.61.2a 2.10.2
UKV lmol/min 1.50.2 1.30.1 1.50.2
FEK % 315 323 332
Urine pH 6.640.25 6.510.19 5.870.24
UTBARSV nmol/min 0.300.12 1.230.20a 0.400.14
Urine osmolality mOsm/kg 1112125 56636a 1142124
Free-water clearance (CH2O) lL/min 424 406 564
Abbreviations are: MAP, mean arterial pressure; Ht, hematocrit; RBF, renal blood flow; RVR, renal vascular resistance; GFR, glomerular filtration rate; UNaV,
urinary excretion of sodium; FENa, fractional excretion of sodium; UKV, urinary excretion of potassium; FEK, fractional excretion of sodium; UTBARSV, urinary excretion
of thiobarbituric acid reactive substances.
aP  0.05 vs. baseline
Fig. 2. Renal blood flow autoregulation during baseline conditions and
during infusion of hypoxanthine and xanthine oxidase (HX/XO). Fig. 3. Degree of compensation during baseline conditions and during
infusion of hypoxanthine and xanthine oxidase (HX/XO).
calculated degree of compensation [19] did not change
gested that enhanced breakdown of adenosine triphos-significantly after initiation of the HX/XO infusion (Fig.
phate (ATP) to adenosine and xanthine leads to increased3). The calculated lower limit of autoregulation was 88
production of O•2 by XO [2], that would cause functional5 before and 85 3 mm Hg during HX/XO infusion (NS).
and structural damage. O•2 has been implicated in the
natriuresis and the decrease in glomerular filtration and
DISCUSSION blood flow following ischemia/reperfusion in several re-
In a variety of clinical situations such as successful ports [7, 16, 17]. Besides O•2 , other candidates have been
cardiopulmonary resuscitation, suprarenal aortic sur- reported that could be (partially) responsible for the
gery, cardiac surgery, and in a transplanted kidney, blood sustained changes renal function, in particular endothelin
flow and oxygen delivery to the kidney is temporarily [25], serotonin via the 5-hydroxy-tryptamine (5-HT2) re-
interrupted. Quite frequently, renal function following ceptor [18], adenosine [23], and atrial natriuretic peptide
ischemia and reperfusion deteriorates, fractional sodium (ANP) [26]. In the present study, we addressed the ques-
excretion is extremely high and GFR, RBF, and RBF tion to which extent an elevation in O•2 , generated by
autoregulation are severely compromised. Besides these the same system that is held responsible for O•2 produc-
functional changes, tubular necrosis and increased num- tion in ischemia/reperfusion, can explain the natriuresis
bers of infiltrating neutrophils can be observed by histol- observed in ischemia/reperfusion.
ogy [23, 24]. Severely impaired renal function is quite The present study demonstrates that increasing pre-
often sustained for such a critical period that renal re- vailing O•2 levels by concomitant infusion of HX and
XO leads to a very strong decrease in renal sodiumplacement therapy becomes necessary. It has been sug-
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reabsorption, which is acutely reversible. HX/XO infu- bly occurred in the absence of major changes in the
peritubular capillary hydrostatic pressure, as there weresion slightly decreased GFR and RBF and increased
RVR. Increasing O•2 by a HX/XO infusion did not affect no consistent changes in systemic blood pressure and
filtration fraction. Glomerulotubular balance is classi-the efficacy of RBF autoregulation. Despite the large
number of studies indicating renal actions of O•2 in cally viewed as a proximal tubular phenomenon [29].
Although the present study does not clearly indicate aischemia/reperfusion damage, direct renal actions of ele-
vated O•2 in vivo have not yet been tested. The reaction proximal or distal action of the increased superoxide, an
increase of the fractional excretion of sodium to aboutof HX with XO mimics the functional changes observed
in ischemia/reperfusion. Moreover, we observed a sig- 7.5% is hardly compatible with a purely distal phenome-
non. Aspecific or osmotic effects of the substances usednificant and completely reversible increase in urinary
excretion of TBARS, a measure of lipid peroxidation is unlikely. HX alone was ineffective, and the osmotic
load infused in the experimental period was only 300[22], indicating that during HX/XO infusion, the kidneys
were exposed to an increase in oxidative stress. As there nmol/min (i.e., HX 10 mmol/L 30 uL/min), as compared
to the excreted sodium load that increased from 1700 towas no change in protein or glucose excretion, and micro-
scopic examination of the kidneys revealed no injury, 8600 nmol/min.
Concomitant infusion of HX and XO resulted in athe effect seems to be functional and acutely reversible.
Conflicting data on tubular actions of increased O•2 slight but significant decrease in GFR and RBF, and
increase in renal vascular resistance. This in accordancehave been reported. Decreases in sodium excretion have
been demonstrated following infusion of the O•2 dismu- with indirect evidence for renal hemodynamic actions
of O•2 from studies in spontaneously hypertensive ratstase inhibitor diethyl dithiocarbamate in dogs [10] and
in rats [12]. In the isolated perfused kidney, HX/XO (SHR). In SHR, chronic and acute treatment with the
SOD-mimetic tempol resulted in a decrease in MAP andreduced urine flow and sodium excretion proportional
to the decrease in GFR; fractional changes were not RVR [11]. Somewhat more direct evidence for renal
hemodynamic actions of O•2 is available from studiesobserved [5], while in another study oxidized low-density
lipoprotein (LDL) infusion increased fractional sodium in isolated perfused kidneys. GFR decreased by 70%
when HX and XO were infused into the isolated kidneyexcretion [6]; however; a drawback of this model is intrin-
sic ischemia. Comparison with the present data is obvi- and RVR increased by 50% [5]. In another study, infu-
sion of oxidized LDL into isolated perfused kidney prep-ously hampered by the differences between the in vivo
and in vitro state of the kidneys. In in vivo studies of aration led to a transient decrease in renal perfusate
flow [6]. Ex vivo studies in isolated microperfused rabbitischemia/reperfusion in rats, large increases in the frac-
tional excretion of sodium following reperfusion were afferent arterioles have shown that paraquat-induced
O•2 synthesis has a vasoconstrictive effect that can bemitigated, but not prevented, by pretreatment with either
tempol, desferrioxamine [17], or scavengers such as reversed by tempol [30]. Thus, the present observation
that O•2 leads to a renal vasoconstriction is compatiblemesna (a sulph-hydryl compound) [16], or N-acetyl-
l-cysteine (NAC) [7]; however, this model is characterized with maneuvers affecting endogenous O•2 . We extended
the observations by evaluating RBF autoregulation. Theby extensive proximal tubular damage [16, 17]. Treat-
ment with -melanocyte–stimulating hormone, a neuro- effects of HX/XO infusion were negligible as compared
to the baseline situation with regard to the autoregulatorypeptide with anti-inflammatory actions, reduced the high
fractional excretion of sodium to control levels, by par- characteristics of RBF. Thus, O•2 cannot be held responsi-
ble for the impaired autoregulation observed in ischemia/tially preventing the ischemia-induced down-regulation
of renal sodium transporters [27]. Yoshioka, Ichikawa, reperfusion [18]. Nevertheless, one could pose that there
may be clinical settings where nitric oxide availability isand Fogo [28] showed a sixfold increase in urine flow
that accompanied transient glomerular proteinuria after also impaired. In such a setting, O•2 may indeed impair
RBF autoregulation and by doing so, make the kidneyintrarenal infusion of H2O2. Sodium excretion was not
evaluated in this study, but no changes in GFR or renal more vulnerable for a second hypotensive insult. Inter-
estingly, renal dysfunction after infrarenal aortic aneu-plasma flow were found [28]. Thus, studies on sodium
excretion during manipulations of O•2 are conflicting, rysm repair was ameliorated by supplementation with
antioxidants [31]. Patients with persistent hypofiltrationprobably because of vast differences in sodium delivery
and reabsorption in the baseline situation. after renal transplantation also show persistent decreased
sodium reabsorption [4]. There are no reports availableThe strong increase in urine flow and sodium excretion
that we observed during intrarenal O•2 infusion in nor- of beneficial effects of antioxidants on acute renal failure
after renal transplantation in humans. However, benefi-mal euvolemic rats, accompanied a significant decrease
in GFR and RBF and no appreciable change in systemic cial effects have recently been reported with NAC after
experimental renal transplantation [32] and after renalblood pressure, showing that O•2 is able to completely
disrupt the glomerulotubular balance. This effect proba- ischemia induced by inferior vena cava occlusion above
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12. Zou AP, Li N, Cowley AW Jr: Production and actions of superox-the renal veins (similar to what is observed during the
ide in the renal medulla. Hypertension 37(Pt 2):547–553, 2002
anhepatic phase of the liver transplant) [7, 33]. 13. Laursen JB, Rajagopalan S, Galis Z, et al: Role of superoxide
in angiotensin II-induced but not cathecolamine-induced hyperten-
sion. Circulation 95:588–593, 1997
CONCLUSION 14. Chabrashvili T, Tojo A, Onozato ML, et al: Expression and
cellular localization of classic NADPH oxidase subunits in the spon-Infusion of HX and XO, which is the proposed path- taneously hypertensive rat kidney. Hypertension 39:269–274, 2002
way for O•2 formation in ischemia/reperfusion, leads to 15. Cosentino F, Patton S, d’Uscio LV, et al: Tetrahydrobiopterin
alters superoxide and nitric oxide release in prehypertensive rats.profound natriuresis and less pronounced vasoconstric-
J Clin Invest 101:1530–1537, 1998tion. RBF autoregulation is not affected. The absence 16. Mashiach E, Sela S, Weinstein T, et al: Mesna: A novel renopro-
of proteinuria and morphologic tubular changes, in the tective antioxidant in ischaemic acute renal failure. Nephrol Dial
Transplant 16:542–551, 2001face of excess intrarenal superoxide formation, corrobo-
17. Chatterjee PK, Cuzzocrea S, Brown PAJ, et al: Tempol, a mem-rated by increased urinary TBARS excretion, indicates brane-permeable radical scavenger, reduces oxidant stress mediated
that this model represents a stage prior to that when renal dysfunction and injury in the rat. Kidney Int 58:658–673, 2000
18. Verbeke M, Van de Voorde J, de Ridder L, Lameire N: Influencetubular necrosis is already present. Thus, superoxide can
of ketanserin on experimental loss of renal blood flow autoregula-markedly affect glomerulotubular balance by diverging
tion. Kidney Int 54(Suppl 67):S238–S241, 1998
actions on renal hemodynamics and reabsorptive func- 19. Turkstra E, Braam B, Koomans HA: Impaired renal blood flow
autoregulation in two-kidney, one-clip hypertensive rats is causedtion and could mediate the functional tubular conse-
by enhanced avtivity of nitric oxide. J Am Soc Nephrol 11:847–855,quences of ischemia/reperfusion.
2000
20. Heyrowski A: A new method for determination of inulin in plasma
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